سوق حاجز الالتصاق - النمو والاتجاهات وتأثير COVID-19 والتوقعات (2023 - 2028)

Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

      1. 4.2.1 Increase in the Volume of Surgeries and Sports-Related Injuries

      2. 4.2.2 Rising Awareness About the Medical Implications of Adhesions

   3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Surgical Procedures Coupled With Side Effects Associated With Adhesion Barriers

      2. 4.3.2 Stringent Regulations Resulting in Limited Technological Innovations

   4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 By Product

      1. 5.1.1 Synthetic Adhesion Barriers

         1. 5.1.1.1 Hyaluronic Acid

         2. 5.1.1.2 Regenerated Cellulose

         3. 5.1.1.3 Polyethylene Glycol

         4. 5.1.1.4 Others

      2. 5.1.2 Natural Adhesion Barriers

         1. 5.1.2.1 Collagen

         2. 5.1.2.2 Fibrin

   2. 5.2 By Formulation

      1. 5.2.1 Film

      2. 5.2.2 Liquid

      3. 5.2.3 Gel

   3. 5.3 By Application

      1. 5.3.1 General/Abdominal Surgeries

      2. 5.3.2 Gynecological Surgeries

      3. 5.3.3 Cardiovascular Surgeries

      4. 5.3.4 Orthopedic Surgeries

      5. 5.3.5 Neurological Surgeries

      6. 5.3.6 Others

   4. 5.4 Geography

      1. 5.4.1 North America

         1. 5.4.1.1 United States

         2. 5.4.1.2 Canada

         3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

         1. 5.4.2.1 Germany

         2. 5.4.2.2 United Kingdom

         3. 5.4.2.3 France

         4. 5.4.2.4 Italy

         5. 5.4.2.5 Spain

         6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

         1. 5.4.3.1 China

         2. 5.4.3.2 Japan

         3. 5.4.3.3 India

         4. 5.4.3.4 Australia

         5. 5.4.3.5 South korea

         6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

         1. 5.4.4.1 GCC

         2. 5.4.4.2 South Africa

         3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

         1. 5.4.5.1 Brazil

         2. 5.4.5.2 Argentina

         3. 5.4.5.3 Rest of South America

6. 6. COMPETITIVE LANDSCAPE

   1. 6.1 Company Profiles

      1. 6.1.1 Anika Therapeutics

      2. 6.1.2 Baxter International

      3. 6.1.3 Leader Biomedical

      4. 6.1.4 Betatech Medical

      5. 6.1.5 FzioMed

      6. 6.1.6 Innocoll Holdings

      7. 6.1.7 Integra LifeSciences Holdings Corporation

      8. 6.1.8 Johnson & Johnson

      9. 6.1.9 MAST Biosurgery

   2. *List Not Exhaustive

7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS